Nuveen Asset Management’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.56M | Sell |
216,926
-17,504
| -7% | -$126K | ﹤0.01% | 2487 |
|
|
2024
Q3 | $1.44M | Sell |
234,430
-430,628
| -65% | -$2.64M | ﹤0.01% | 2589 |
|
|
2024
Q2 | $4.42M | Sell |
665,058
-247,942
| -27% | -$1.65M | ﹤0.01% | 2015 |
|
|
2024
Q1 | $9.29M | Sell |
913,000
-814,316
| -47% | -$8.29M | ﹤0.01% | 1640 |
|
|
2023
Q4 | $19.4M | Sell |
1,727,316
-1,719,462
| -50% | -$19.3M | 0.01% | 1180 |
|
|
2023
Q3 | $8.96M | Sell |
3,446,778
-12,171
| -0.4% | -$31.6K | ﹤0.01% | 1540 |
|
|
2023
Q2 | $12.2M | Buy |
3,458,949
+190,888
| +6% | +$674K | ﹤0.01% | 1378 |
|
|
2023
Q1 | $35.7M | Buy |
3,268,061
+2,098
| +0.1% | +$22.9K | 0.01% | 710 |
|
|
2022
Q4 | $53.7M | Buy |
3,265,963
+52,063
| +2% | +$856K | 0.02% | 516 |
|
|
2022
Q3 | $41M | Buy |
3,213,900
+149,620
| +5% | +$1.91M | 0.02% | 607 |
|
|
2022
Q2 | $35.9M | Sell |
3,064,280
-180,924
| -6% | -$2.12M | 0.01% | 698 |
|
|
2022
Q1 | $22.2M | Buy |
3,245,204
+949,372
| +41% | +$6.49M | 0.01% | 1138 |
|
|
2021
Q4 | $19.4M | Buy |
2,295,832
+1,490,012
| +185% | +$12.6M | 0.01% | 1248 |
|
|
2021
Q3 | $12.3M | Buy |
805,820
+567,253
| +238% | +$8.65M | ﹤0.01% | 1639 |
|
|
2021
Q2 | $2.35M | Buy |
+238,567
| New | +$2.35M | ﹤0.01% | 2630 |
|